Analyst Profile

Followed by 704 followers
.
Ryan Zimmerman

Ryan Zimmerman

BTIG
Wall Street Analyst
#1,787 out of 8,141 Wall Street Analysts
#3,727 out of 24,284 experts

Success Rate

42%
176 out of 418 transactions made a profit

Average Return

+4.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Ryan Zimmerman's trades since 2018 and holding each position for 1 Year would result in 42.11% of your transactions generating a profit, with an average return of 4.6% per rating.

Stock Rating Distribution

786Ratings
73.92% Buy
26.08% Hold
0.00% Sell
Distribution of Ryan Zimmerman's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Organogenesis Holdings
(ORGO)
Rating:Buy
Date:Apr 08, 2020 - Apr 08, 2021
Return:+574.80%
The most profitable rating made by Ryan Zimmerman

Ryan Zimmerman's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Ocugen
Dec 24, 2018
Hold
Reiterated
10Ratings
0.00%
Abbott Labs
Aug 27, 2020
Hold
Assigned
2Ratings
0.00%
ConforMIS
Aug 28, 2020
Hold
Assigned
25Ratings
60%
+53.40%
Inari Medical
Dec 03, 2020
Buy
Reiterated
$92.00
(24.61% Upside)
1Ratings
100%
+20.00%
Orthofix
Jul 02, 2021
Hold
Assigned
29Ratings
50%
+2.90%
Electrocore
Jul 30, 2021
Hold
Assigned
12Ratings
0%
-42.91%
Surgalign Holdings
Aug 06, 2021
Buy
Assigned
$75.00
(3118.88% Upside)
4Ratings
0%
-83.70%
XENT
Intersect ENT
Aug 09, 2021
Hold
Downgraded
16Ratings
100%
+37.74%
MSON
Misonix
Oct 29, 2021
Hold
Assigned
17Ratings
83%
+52.47%
Mediwound
Oct 14, 2022
Hold
Assigned
19Ratings
0%
-38.57%
List of latest recommendations made by Ryan Zimmerman. Click to expand and see Ryan Zimmerman's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >